BD showcases drug delivery and packaging at CPhI

Published: 20-Oct-2022

At the booth, BD will show its wide range of services and solutions to "help meet your combination product development needs"

Becton, Dickson and Company (BD) has sponsored CPhI Worldwide Conference – building on its decades of expertise in partnering with the biopharmaceutical industry to advance drug delivery excellence.

CPhI WW will be held in Frankfurt, Germany from 1-3 November, 2022. The conference will focus on product sustainability and innovation across the pharmaceutical supply chain. BD will serve as a Platinum Sponsor and participate in talks throughout the conference, including:

  • “Container Closure Integrity Testing - Deterministic Methods” on 1 November at 11:30 by Kayla Kaspar, Technology Development Manager at ZebraSci
  • “The Next Generation Vaccine Syringe - BD Effivax Glass Prefillable Syringe” on November 1 at 15:00 Vincent Hérin, Associate Director, R&D Program Management
  • “Clinical Evaluation of an Investigational 5ml Wearable Injector” on 1 November at 15:30 by Natasha Bolick, Associate Director, BD Technologies & Innovation

At the booth, BD will show its wide range of services and solutions to help meet your combination product development needs.  BD experts will be on site to discuss a variety of topics related to the next generation of drug delivery, including:

  • BD Effivax Glass Prefillable Syringe – a next-generation glass prefillable syringe that has been designed in collaboration with leading pharmaceutical companies to meet the complex and evolving needs of vaccine manufacturing. BD Effivax Glass Prefillable Syringe sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.
  • BD Evolve On-body Injector – a programmable, variable dose on-body injector. It offers pharmaceutical companies a wearable solution that enables new delivery formats in alternate settings. It is designed to enable subcutaneous administration of up to 3 mL of medication, with up to three days of wear.
  • A complete range of services across BD Pharmaceutical Services and Solutions and ZebraSci combination product services to help you achieve your combination product development goals.
  • An Innovation Corner featuring early concept new product innovations.

BD looks forward to the on-site collaboration with biopharmaceutical partners, as we continue to prioritise drug delivery innovation.

You may also like